IRADIMED CORP - Common (IRMD)

CUSIP: 46266A109

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / Common
Shares outstanding
12,602,265
Total 13F shares
1,280,146
Share change
-79,081
Total reported value
$29,788,794
Price per share
$23.27
Number of holders
38
Value change
-$1,342,477
Number of buys
27
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 46266A109?
CUSIP 46266A109 identifies IRMD - IRADIMED CORP - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IRMD - IRADIMED CORP - Common (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Broadfin Capital, LLC
13F
Company
2.8%
357,364
$5,443,000 31 Mar 2015
13F
SOPHROSYNE CAPITAL LLC
13F
Company
2.7%
339,158
$5,167,000 31 Mar 2015
13F
AWM Investment Company, Inc.
13F
Company
1.7%
210,285
$3,203,000 31 Mar 2015
13F
WASATCH ADVISORS LP
13F
Company
1%
131,562
$2,004,000 31 Mar 2015
13F
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC
13F
Company
0.8%
100,700
$1,534,000 31 Mar 2015
13F
NORTHPOINTE CAPITAL LLC
13F
Company
0.48%
60,275
$918,000 31 Mar 2015
13F
OBERWEIS ASSET MANAGEMENT INC/
13F
Company
0.16%
20,000
$305,000 31 Mar 2015
13F
CONNORS INVESTOR SERVICES INC
13F
Company
0.15%
19,000
$289,000 31 Mar 2015
13F
STIFEL FINANCIAL CORP
13F
Company
0.13%
16,891
$257,000 31 Mar 2015
13F
VANGUARD GROUP INC
13F
Company
0.13%
16,020
$244,000 31 Mar 2015
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.12%
15,404
$235,000 31 Mar 2015
13F
JFS WEALTH ADVISORS, LLC
13F
Company
0.03%
4,200
$64,000 31 Mar 2015
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
3,000
$46,000 31 Mar 2015
13F
MORGAN STANLEY
13F
Company
0.02%
2,566
$39,000 31 Mar 2015
13F
DEUTSCHE BANK AG\
13F
Company
0.02%
2,220
$33,000 31 Mar 2015
13F
UBS Group AG
13F
Company
0.01%
1,013
$15,000 31 Mar 2015
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.01%
718
$11,000 31 Mar 2015
13F
BlackRock Investment Management, LLC
13F
Company
0%
409
$6,000 31 Mar 2015
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
122
$2,000 31 Mar 2015
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0%
100
$2,000 31 Mar 2015
13F
GLOBEFLEX CAPITAL L P
13F
Company
0%
43
$1,000 31 Mar 2015
13F

Institutional Holders of IRADIMED CORP - Common (IRMD) as of Q2 2015

As of 30 Jun 2015, IRADIMED CORP - Common (IRMD) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,280,146 shares. The largest 10 holders included Broadfin Capital, LLC, AWM Investment Company, Inc., GRUBER & MCBAINE CAPITAL MANAGEMENT LLC, WASATCH ADVISORS INC, EAM Investors, LLC, SOPHROSYNE CAPITAL LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., THOMSON HORSTMANN & BRYANT INC, and MORGAN STANLEY. This page lists 38 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders
20
Q2 2015 holders
38
Holder diff
18
Investor Q1 2015 Shares Q2 2015 Shares Share Diff Share Chg % Q1 2015 Value $ Q2 2015 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .